Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M- T1, during myxoma virus pathogenesis

Virology

Volumn 256, Issue 2, 1999, Pages 233-245

  Lalani, Alshad S ^a,b   Masters, Jennefer ^b   Graham, Kathryn ^a   Liu, Liying ^b   Lucas, Alexandra ^b   McFadden, Grant ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; GLYCOPROTEIN M T1; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CYTOKINE PRODUCTION; GENE EXPRESSION; HISTOPATHOLOGY; INOCULATION; MACROPHAGE; MONOCYTE; MYXOMATOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; DNA VIRUSES; MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS; POXVIRIDAE;

EID: 0033541380     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9617     Document Type: Article

References (58)

1. Alcamí A., Smith G. L. A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell. 71:1992;153-167.
2. Alcamí A., Smith G. L. Interleukin-1 receptors encoded by poxviruses. McFadden G. In Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. 1995;17-27 R. G. Landes Company, Austin.
3. Alcamí A., Smith G. L. A mechanism for the inhibition of fever by a virus. Proc. Natl. Acad. Sci. USA. 93:1996;11029-11034.
4. Alcamí A., Symons J. A., Collins P. D., Williams T. J., Smith G. L. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:1998a;624-633.
5. Alcamí A., Symons J. A., Khanna A., Smith G. L. Poxviruses: Capturing cytokines and chemokines. Semin. Virol. 419:1998b;427.
6. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
7. Barry M., Hnatiuk S., Mossman K., Lee S. F., Boshkov L., McFadden G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology. 239:1997;360-377.
8. Barry M., McFadden G. Apoptosis regulators from DNA viruses. Curr. Opin. Immunol. 10:1998a;422-430.
9. Barry M., McFadden G. Virus encoded cytokines and cytokine receptors. Parasitology. 115:1998b;S89-S100.
10. Colamonici O. R., Domanski P., Sweitzer S. M., Larner A., Buller R. M. L. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon α transmembrane signaling. J. Biol. Chem. 270:1995;15974-15978.
11. Falkner F. G., Moss B. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62:1988;1849-1854.
12. Fenner F. Myxomatosis. Parasit. Infect. Dis. 23:1994;337-346.
13. Fenner F., Ratcliffe F. N. Myxomatosis. 1965;Cambridge University Press, Cambridge.
14. Graham K. A., Lalani A. S., Macen J. L., Ness T. L., Barry M., Liu L. Y., Lucas A., Clark-Lewis I., Moyer R. W., McFadden G. The T1/35kDa family of poxvirus secreted proteins bind chemokines and modulate leukocyte influx into virus infected tissues. Virology. 229:1997;12-24.
15. Graham K. A., Opgenorth A., Upton C., McFadden G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical for manifestation of viral virulence. Virology. 191:1992;112-124.
16. Hu F. Q., Smith C. A., Pickup D. J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology. 204:1994;343-356.
17. Kotwal G. J. Microorganisms and their interaction with the immune system. J. Leuk. Biol. 62:1997;415-429.
18. Lalani A. S., Graham K., Mossman K., Rajarathnam K., Clark-Lewis I., Kelvin D., McFadden G. The purified myxoma virus IFN-γ receptor homolog, M-T7, interacts with the heparin binding domains of chemokines. J. Virol. 71:1997;4356-4363.
19. Lalani A. S., McFadden G. Secreted poxvirus chemokine binding proteins. J. Leuk. Biol. 62:1997;570-576.
20. Lalani A. S., Ness T. L., Singh R., Harrison J. K., Seet B. T., Kelvin D. J., McFadden G., Moyer R. W. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology. 250:1998;173-184.
21. Loparev V. N., Parsons J. M., Knight J. C., Panus J. F., Ray C. A., Buller R. M. L., Pickup D. J., Esposito J. J. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA. 95:1998;3786-3791.
22. Lucas A., Liu L. Y., Macen J., Nash P., Dai E., Stewart M., Graham K., Etches W., Boshkov L., Nation P. N., Humen D., Lundstrom-Hobman M., McFadden G. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation. 94:1996;2890-2900.
23. Luster A. D. Chemokines: Chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445.
24. Macaulay C., Upton C., McFadden G. Tumorigenic poxviruses: Transcriptional mapping of the terminal inverted repeats of Shope fibroma virus. Virology. 158:1987;381-393.
25. Macen J. L., Graham K. A., Lee S. F., Schreiber M., Boshkov L. K., McFadden G. Expression of the myxoma virus tumor necrosis factor receptor homologue (T2) and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology. 218:1996;232-237.
26. Macen J. L., Upton C., Nation N., McFadden G. SERP-1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 195:1993;348-363.
27. Martinez-Pomares L., Thompson J. P., Moyer R. W. Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology. 206:1995;591-600.
28. McFadden G. Poxviruses of rabbits. Darai G. Virus Disease in Laboratory and Captive Animals. 1988;37-62 Martinus Nijhoff, Boston.
29. McFadden G. DNA viruses that affect cytokine networks. Aggarwal B. B., Puri R. K. Human Cytokines: Their Role in Health and Disease. 1994;403-422 Blackwell Press, Cambridge.
30. McFadden G. Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. 1995;R. G. Landes Company, Austin.
31. McFadden G., Graham K., Ellison K., Barry M., Macen J., Schreiber M., Mossman K., Nash P., Lalani A., Everett H. Interruption of cytokine networks by poxviruses: Lessons from myxoma virus. J. Leuk. Biol. 57:1995;731-738.
32. McFadden G., Lalani A., Everett H., Nash P., Xu X. Virus- encoded receptors for cytokines and chemokines. Semin. Cell Dev. Biol. 9:1998;359-368.
33. Messud-Petit F., Gelfi J., Delverdier M., Amardeilh M. F., Py R., Sutter G., Bertagnoli S. SERP-2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 72:1998;7830-7839.
34. Moss B. Replication of poxviruses. Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;2637-2671 Lippincott-Raven Press, New York.
35. Mossman K., Barry M., McFadden G. Poxvirus-encoded homologues of the γ-interferon receptor. McFadden G. Viroceptors, Virokines and Related Mechanisms of Immune Modulation by DNA Viruses. 1995a;41-54 R. G. Landes Company, Austin.
36. Mossman K., Lee S. F., Barry M., Boshkov L., McFadden G. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbis. J. Virol. 70:1996a;4394-4410.
37. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 215:1996b;17-30.
38. Mossman K., Upton C., McFadden G. The myxoma virus-soluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species-specific manner. J. Biol. Chem. 270:1995b;3031-3038.
39. Murphy P. M. Chemokine receptors: Structure, function and role in microbial pathogenesis. Cyt. Growth Fact. Rev. 7:1996;47-64.
40. Murphy P. M., Pease J. E. Microbial corruption of the chemokine system: An expanding paradigm. Semin. Immunol. 10:1998;169-178.
41. Nathanson N. Viral Pathogenesis. 1997;Lippincott-Raven Press, Philadelphia.
42. Nelson P. J., Krensky A. M. Chemokines, lymphocytes and viruses: What goes around, comes around. Curr. Opin. Immunol. 10:1998;265-270.
43. Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:1992a;4720-4731.
44. Opgenorth A., Strayer D., Upton C., McFadden G. Deletion of the growth factor gene related to EGF and TGF α reduces virulence of malignant rabbit fibroma virus. Virology. 186:1992b;175-191.
45. Patel A. H., Gaffney D. F., Subak-Sharpe J. H., Stow N. D. DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. J. Gen. Virol. 71:1990;2013-2021.
46. Pickup D. J. Poxviral modifiers of cytokine responses to infection. Infect. Agents Dis. 3:1994;116-127.
47. Ploegh H. L. Viral strategies of immune evasion. Science. 280:1998;248-253.
48. Premack B. A., Schall T. J. Chemokine receptors: Gateways to inflammation and infection. Nat. Med. 2:1996;1174-1178.
49. Schreiber M., Rajarathnam K., McFadden G. Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFα, but the dimer is a more potent TNF inhibitor. J. Biol. Chem. 271:1996;13333-13341.
50. Smith C. A., Smith T. D., Smolak P. J., Friend D., Hagen H., Gerhart M., Park L., Pickup D. J., Torrance D., Mohler K., Schooley K., Goodwin R. G. Poxvirus genomes encode a secreted soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 236:1997;316-327.
51. Smith G. L. Virus strategies for evasion of the host response to infection. Trends Microbiol. 2:1994;81-88.
52. Spriggs M. K. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 14:1996;101-131.
53. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M., VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell. 71:1992;145-152.
54. Symons J. A., Alcamí A., Smith G. L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 81:1995;551-560.
55. Tsukada T., Rosenfeld M., Ross R., Gown A. M. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Arteriosclerosis. 6:1986;601-613.
56. Upton C., Macen J. L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 184:1991;370-382.
57. Upton C., Mossman K., McFadden G. Encoding of a homolog of the interferon-γ receptor by myxoma virus. Science. 258:1992;1369-1372.
58. Wells T. N. C., Schwartz T. W. Plagiarism of the host immune system: Lessons about chemokine immunology from viruses. Curr. Opin. BioTechniques. 8:1998;741-748.